Virtual Reality Exergaming on Heart Rate, Perceived Exertion, and Technology Acceptance in Healthy Individuals
- Drug/Device/Intervention
- Meta Oculus Quest 2™ Virtual Reality Exergaming
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Teesside University
- Location
- Middlesbrough, United Kingdom
- Phase
- N/A
- Start date
- Jan 01, 2023
- End date
- Jan 31, 2023
- Enrollment
- 9 participants
Rate of Perceived Exertion (RPE),Heart Rate (HR),Technology Acceptance
This pilot cohort study aimed to investigate the immediate impact of Virtual Reality (VR)
 exergaming on heart rate (HR), rate of perceived exertion (RPE), and technology acceptance
 using the Unified Theory of Acceptance and Use of Technology (UTAUT) in healthy adults.
 Participants engaged in a 20-minute session of VR exergaming using the Meta Oculus Quest 2™
 headset. HR and RPE were measured at baseline, during, and after the intervention, while
 technology acceptance was assessed pre- and post-intervention using the UTAUT questionnaire.
 
 The results showed that VR exergaming increased HR while maintaining perceived exertion at
 low to moderate levels. Technology acceptance also improved significantly across all domains
 measured by UTAUT, with particularly notable increases in Performance Expectancy and Effort
 Expectancy. The findings suggest that VR exergaming is an effective method to enhance
 physical activity, motivation, and engagement, providing promising support for its use as a
 rehabilitation tool for individuals struggling with adherence and motivation.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06411119
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06411119 through Pure Global AI's free database. This phase not specified trial is sponsored by Teesside University and is currently Completed. The study focuses on Healthy,Physical Activity,Virtual Reality,Exergame,Inactivity, Physical. Target enrollment is 9 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.